Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Sanchez

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
La Revue Du Praticien|March 8, 2003
[Chemical and electrical burns]Raymond Sanchez
Prevention Science : the Official Journal of the Society for Prevention Research|April 28, 2012
Tobacco outlet density and demographics: a geographically weighted regression analysisRaymond Sanchez Mayers, Lyna L Wiggins, Fontaine H Fulghum, et al.
Contemporary Clinical Trials|January 26, 2023
Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsorStacey Versavel, Alicia Subasinghe, Kenasha Johnson, et al.
Current Medical Research and Opinion|May 1, 2010
Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind studyEduard Vieta, Randall Owen, Christine Baudelet, et al.
Bipolar Disorders|March 30, 2011
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized studyRonald Marcus, Arif Khan, Linda Rollin, et al.
Clinical Therapeutics|August 6, 2015
Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of SuccessHaruhiko Sugino, Akihito Watanabe, Naoki Amada, et al.
Journal of Clinical Psychopharmacology|April 5, 2019
A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive DisorderMary Hobart, Peter Zhang, Aleksandar Skuban, et al.
Research Square|October 13, 2021
Substance Use Workforce Training Needs during Intersecting Epidemics: An Analysis of Events Offered by a Regional Training Center from 2017-2020Kelli Scott, Mika D H Salas, Denise Bayles, et al.
BMC Public Health|June 1, 2022
Substance use workforce training needs during intersecting epidemics: an analysis of events offered by a regional training center from 2017 to 2020Kelli Scott, Mika D H Salas, Denise Bayles, et al.
The Journal of Clinical Psychiatry|March 6, 2007
Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazineJohn M Kane, Herbert Y Meltzer, William H Carson, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
La Revue Du Praticien|March 8, 2003
[Chemical and electrical burns]Raymond Sanchez
Prevention Science : the Official Journal of the Society for Prevention Research|April 28, 2012
Tobacco outlet density and demographics: a geographically weighted regression analysisRaymond Sanchez Mayers, Lyna L Wiggins, Fontaine H Fulghum, et al.
Contemporary Clinical Trials|January 26, 2023
Diversity, equity, and inclusion in clinical trials: A practical guide from the perspective of a trial sponsorStacey Versavel, Alicia Subasinghe, Kenasha Johnson, et al.
Current Medical Research and Opinion|May 1, 2010
Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind studyEduard Vieta, Randall Owen, Christine Baudelet, et al.
Bipolar Disorders|March 30, 2011
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized studyRonald Marcus, Arif Khan, Linda Rollin, et al.
Clinical Therapeutics|August 6, 2015
Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of SuccessHaruhiko Sugino, Akihito Watanabe, Naoki Amada, et al.
Journal of Clinical Psychopharmacology|April 5, 2019
A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive DisorderMary Hobart, Peter Zhang, Aleksandar Skuban, et al.
Research Square|October 13, 2021
Substance Use Workforce Training Needs during Intersecting Epidemics: An Analysis of Events Offered by a Regional Training Center from 2017-2020Kelli Scott, Mika D H Salas, Denise Bayles, et al.
BMC Public Health|June 1, 2022
Substance use workforce training needs during intersecting epidemics: an analysis of events offered by a regional training center from 2017 to 2020Kelli Scott, Mika D H Salas, Denise Bayles, et al.
The Journal of Clinical Psychiatry|March 6, 2007
Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazineJohn M Kane, Herbert Y Meltzer, William H Carson, et al.
Pageof 6